IJGC conversations

ijgcgroup
  • 0.0 (0)
  • MEDICINE

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

  1. 17 HR AGO

    ctDNA & diagnosis of ovarian cancer with Cristina Taliento and Giuseppe Vizzielli

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Cristina Taliento and Giuseppe Vizzielli to discuss ctDNA & diagnosis of ovarian cancer.   Cristina Taliento is a gynecologist and PhD candidate in a joint PhD program at the University Hospital of Ferrara, Italy, and KU Leuven, Belgium, associated with the International Ovarian Tumour Analysis (IOTA) Group. She completed a Research Fellowship at the European Institute of Oncology in Milan. She recently started her Fellowship Training in Gynecologic Oncology at the University Hospital of Heidelberg, Germany. Her PhD research focuses on clinical and translational studies in the diagnosis and management of adnexal tumors, with a particular interest in circulating tumor DNA in ovarian cancer.   Giuseppe Vizzielli is an associate professor of gynecology and obstetrics at the Department of Medicine, University of Udine, and Chief of the Gynecologic Oncology Unit at University Hospital of Udine, Italy. He completed his Ph.D. studies in molecular pathology in gynaecological oncology at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma. He is a member of the European Society of Gynaecological Oncology (ESGO) and a member of the Italian Society of Gynaecological Endoscopy (SEGI), affiliated with the ESGE. He was the principal investigator of the national research project,  Longitudinal genomic and transcriptomic analysis on ovarian cancer organoids. He serves as an official reviewer of many indexed international journals as well as Lancet Oncology, the International Journal of Gynecological Cancer, the European Journal of Surgical Oncology, World Journal of Surgical Oncology, European Journal of Obstetrics and Gynecology and Reproductive Biology, Archives of Gynecology and Obstetrics, and BMC Cancer, and he is an associate editor of BMC Cancer, Cancers and the World Journal of Surgical Oncology. His recent publication in IJGC focuses on Circulating tumor DNA in the diagnosis of ovarian cancer.

    39 min

  2. 6 DAYS AGO

    IJGC conversations 2025 December Editor's Choice

    In this episode of the IJGC conversations 2025 December Editor's Choice, Editorial Fellow Itziar Villagrá, Joannie Neveu, and Mathilde Del discusses the contents of the 2025 December issue of IJGC.

    12 min

  3. 08/12/2025

    Revisited: ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy with Frédéric Amant

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Frédéric Amant to discuss ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy.   Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended his thesis on uterine sarcomas in 2002 at the KU Leuven. He is specialist at the UZ Leuven in Belgium. He is professor at the KU Leuven in Belgium and at the University of Amsterdam in the Netherlands, and honorary professor at the university of Pretoria, South Africa. Since 2024 he is council member of the European Society of Gynecologic Oncology. Frédéric Amant heads the Gynecologic Oncology research section at the University of Leuven, Belgium and at the Netherlands Cancer Institute. In 2005 he founded the “International Network on Cancer, Infertility and Pregnancy” (INCIP)(www.cancerinpregnancy.org), and chairs this network up till now. Since 2014, INCIP also registers young women who aim to preserve their fertility. In 2021 he launched the Advisory Board Cancer Infertility Pregnancy (ABCIP) under the umbrella of INCIP. In addition, Frédéric Amant founded Trace, the tumor xenograft platform at the KU Leuven and the Fund for Innovative Research at the KU Leuven. He co-founded ENITEC, the European Network on Individualized Treatment of Endometrial Cancer. Since 2024 he is member of the research council at the KU Leuven.

    41 min

  4. 01/12/2025

    SUROVA Study: Surgery vs Neoadjuvant Therapy in Ovarian Cancer with Luis Chiva

    In this IJGC podcast, Dr. Pedro Ramirez discusses SUROVA Study: Surgery vs Neoadjuvant Therapy in Ovarian Cancer with Luis Chiva.   Prof. Luis M. Chiva, MD, PhD, is Chair of Obstetrics and Gynecology and Professor of Gynecology and Medical Ethics at the University of Navarra in Pamplona, Spain. An internationally recognized leader in gynecologic oncology, he is renowned for his expertise in complex pelvic oncologic surgery and his commitment to advancing surgical quality and patient-centered care. A graduate of the University of Madrid, Dr. Chiva completed his gynecologic oncology fellowship at Rush-Presbyterian–St. Luke’s Medical Center in Chicago. He later directed the Gynecologic Oncology Department at MD Anderson Cancer Center Madrid and established educational collaborations with MD Anderson Houston. Dr. Chiva has authored over 100 peer-reviewed publications, delivered more than 300 invited lectures, and spearheaded key educational initiatives such as the international “Meet the Surgeon” program. He has held major leadership roles within ESGO, including serving as council member, chair of the Quality Assurance and Certification Committee, and Editor-in-Chief of the ESGO e-Academy platform. He was presented for Honorary Fellowship in the American College of Surgeons in 2021.

    40 min

  5. 24/11/2025

    Updates in Radiotherapy in Gynecologic Cancers with Junzo Chino

    In this IJGC podcast, Dr. Pedro Ramirez discusses Updates in Radiotherapy in Gynecologic Cancers with Junzo Chino.   Dr. Chino is an Associate Professor of Radiation Oncology and Director of Brachytherapy at the Duke Cancer Center. He has authored over 100 publications in the peer reviewed literature, and his research interests are concentrated in radiation therapy for gynecologic cancer, as well as health services and disparities. He was lead author of the ASTRO guidelines task force for cervical cancer, and served as the GYN section editor at the International Journal of Radiation Oncology Biology and Physics and Associate Editor of the International Journal of Gynecological Cancer. His recent article published in Cancer focuses on Recent advances in gynecologic radiation oncology.

    39 min

  6. 22/11/2025

    IJGC conversations 2025 November Editor's Choice

    In this episode of the IJGC conversations 2025 November Editor's Choice, Editorial Fellow Paula Mateo-Kubach and Matteo Loverro discusses the contents of the 2025 November issue of IJGC.

    15 min

  7. 17/11/2025

    Results of the MoST-CIRCUIT Trial with Oliver Klein

    In this IJGC podcast, Dr. Pedro Ramirez discusses Results of the MoST-CIRCUIT Trial with Oliver Klein.   A/Prof Klein is a clinician-scientist at the Austin Hospital and the ONJCRI with a 20-year experience in the field of cancer immunotherapy and a particular interest in the treatment of rare gynaecological malignancies. Dr Klein pioneered clinical trials using checkpoint blockade in patients with advanced rare cancers including gynaecological malignancies. These trials demonstrated unprecedented clinical outcomes in this patient population of major unmet medical need. Next to his clinical research, Dr Klein participates and leads translational research investigating biological correlates of response to immunotherapy.

    37 min

  8. 12/11/2025

    Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer

    In this IJGC podcast, Dr. Pedro Ramirez discusses Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer.   Dr. Marina Frimer is a gynecologic oncologist and physician-scientist whose work bridges clinical innovation and translational research in gynecologic malignancies. As Associate Professor at the Zucker School of Medicine at Hofstra/Northwell and Associate Chief for Research and Academic Development at Northwell Health, she plays a key role in advancing academic and clinical research programs in women’s cancer. Dr. Frimer’s research focuses on improving surgical and therapeutic outcomes in gynecologic oncology, with a particular emphasis on uterine and endometrial cancers. Her recent publications include a phase II clinical trial investigating niraparib maintenance therapy in uterine serous carcinoma (BMJ Open, 2025), studies on perioperative antibiotic optimization for hysterectomy in gynecologic malignancies (Int J Gynecol Cancer, 2025), and patient-derived organoid models of endometrial cancer (Bio Protoc, 2024).   Dr. Frimer has contributed to influential studies on DNA repair mechanisms, endometrial microbiome, and racial disparities in endometrial cancer. Her work has been published in leading journals such as Gynecologic Oncology, JCO Precision Oncology, and International Journal of Gynecological Cancer, and she has collaborated extensively on multi-institutional and translational research initiatives. Dr. Frimer is recognized for her leadership in mentoring early-career investigators and promoting clinical trial development within Northwell’s gynecologic oncology research program.   Dr. Megan Gorman is a gynecologic oncologist and Assistant Professor at Thomas Jefferson University Hospital in Philadelphia, PA.  Dr. Gorman completed her medical education at the Warren Alpert Medical School of Brown University, her training in obstetrics and gynecology at Stony Brook University Hospital, her fellowship in gynecologic oncology at Zucker School of Medicine at Hofstra/Northwell Long Island Jewish Medical Center. Her recent clinical research in gynecologic malignancies focuses on racial disparities in cancer care, improved surgical outcomes, funding disparities in research,  the role of next generation sequencing, novel therapies, end of life care, and hormone replacement in survivorship. She has also collaborated on translational research initiatives including the development of a patient-derived organoid model of endometrial cancers. Dr. Gorman is passionate about resident education, promoting health literacy, and the treatment of HPV-associated malignancies, and recently completed her second medical mission in Salima, Malawi.

    32 min
See All (58)

About

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

Information

  • Creator
    ijgcgroup
  • Years Active
    2024 - 2026
  • Episodes
    58
  • Rating
    Clean
  • Copyright
    © Copyright 2024 All rights reserved.
  • Show Website
    IJGC conversations

You Might Also Like